← Back to all trials
Not Yet Recruiting
NCT05705544
Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)
Conditions: Peripheral Pulmonary Lesions
Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 500
Sponsor: Vanderbilt University Medical Center
Location: United States
Summary
This is an investigator-initiated, cluster randomized controlled trial.
The primary objective is to compare the diagnostic yield of the Ion™ Endoluminal System (SSCB) to the ILLUMISITE™ Platform (EMN bronchoscopy) in patients undergoing bronchoscopy for peripheral pulmonary lesion (PPL) evaluation.
Eligibility Criteria
Inclusion Criteria:≥ 18 years of age at time of bronchoscopy.Scheduled for navigational bronchoscopy for the evaluation of a peripheral pulmonary lesion.Exclusion Criteria:• Enrolled in a different study requiring use of one of these specific platforms (i.e., ILLUMISITE™ Platform (EMN) or Ion™ Endoluminal System (SSCB)).
Source: ClinicalTrials.gov (NCT05705544). StuddyBuddy aggregates publicly available trial information.
